Home/Filings/4/0001628280-23-007971
4//SEC Filing

Looker Benjamin 4

Accession 0001628280-23-007971

CIK 0001434868other

Filed

Mar 14, 8:00 PM ET

Accepted

Mar 15, 9:23 AM ET

Size

10.9 KB

Accession

0001628280-23-007971

Insider Transaction Report

Form 4
Period: 2023-03-14
Looker Benjamin
General Counsel
Transactions
  • Award

    Common Stock

    2023-03-14+20,50084,953 total
  • Award

    Stock Option (right to buy)

    2023-03-14+86,90086,900 total
    Exercise: $4.02Exp: 2033-03-14Common Stock (86,900 underlying)
Footnotes (2)
  • [F1]Such award will vest over a four (4) year period in equal quarterly installments, the first of which shall be on June 15, 2023, subject to continued service.
  • [F2]Such options will vest over a four (4) year period in equal quarterly installments, the first of which shall be on June 15, 2023, subject to continued service.

Issuer

Esperion Therapeutics, Inc.

CIK 0001434868

Entity typeother

Related Parties

1
  • filerCIK 0001859509

Filing Metadata

Form type
4
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 9:23 AM ET
Size
10.9 KB